Fabry disease

Fabry disease
Biotech

Cash-strapped Sangamo seeks partner for new gene therapy

Sangamo Therapeutics’ investigational gene therapy appears to improve kidney function at 52 weeks for patients with a rare genetic disorder.
Gabrielle Masson Jun 24, 2025 11:53am
water tap outside

4DMT restructures pipeline, extending cash runway through 2028

Jan 10, 2025 2:00pm
pedal to metal fast car speed gas

Sangamo slashes time to market for Fabry gene therapy

Oct 22, 2024 12:57pm
Lego building blocks build toy

Relay loses interest in SHP2 inhibitor after Genentech leaves

Aug 7, 2024 6:00am
Crossing crosswalk walking road

Crosswalk grabs compounds from abandoned Takeda, Codexis collab

Jul 2, 2024 9:55am
Graphic of employees walking out depicting layoffs

Sangamo lays off 27% of US staff in latest refocus

Apr 27, 2023 8:55am